• INCEPTION (03/05/2011)

  • 7 YRS
  • AVG. ANNUAL RETURN

  • 23.94%
  • S&P RETURN

  • 13.06%
(HIBEV) Hagopian Institute BioMed Extreme Value

HIBEV Growth of $10,000

HIBEV Model
HIBEV Composite
S&P 500

HIBEV Month By Month (As Of: 07/13/2018)


Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec HIBEV YTD S&P YTD
2018-4.52%-5.24%0.19%-0.91%8.72%-0.51%6.63%-----3.61% 5.86%
20178.52%12.99%1.48%-2.66%-2.31%10.51%5.73%0.51%1.63%-2.29%-2.31%-3.22%30.46% 21.83%
2016-9.78%-4.52%-2.17%-0.35%3.47%-9.57%9.09%-4.42%7.36%-14.75%5.53%-0.48%-21.24% 11.96%
20155.24%-0.87%-2.15%-5.77%21.38%1.91%8.11%-9.48%-10.96%8.83%2.77%-1.95%13.70% 1.38%
20148.41%10.33%-9.02%1.54%4.09%7.16%-8.13%9.44%-3.60%7.12%1.01%-3.27%25.02% 13.69%
20136.02%5.05%7.82%0.87%1.05%1.87%14.62%5.99%9.66%2.56%15.81%7.12%111.31% 32.39%
201214.37%8.13%-0.19%9.39%-10.63%4.12%4.87%3.99%11.85%-13.10%3.89%-5.27%31.09% 16.00%
2011--6.36%-3.22%-2.35%0.12%3.13%-2.06%-6.86%3.73%7.64%11.27%17.63% -3.13%
Returns greater than 5%
Returns less than -5%

HIBEV Composite Month By Month (As Of: 05/31/2018)


Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec HIBEV YTD S&P TR YTD
2018-4.26%-5.29%-0.52%-0.85%9.80%--------1.80% 2.02%
20178.61%13.22%1.65%-2.51%-2.84%8.92%6.12%1.50%0.32%-2.56%-1.81%-2.87%29.50% 21.83%
2016----0.06%3.55%-9.03%9.25%-4.31%7.42%-14.78%5.08%0.14%-5.20% 10.04% **
Returns greater than 5%
Returns less than -5%

**The S&P return represents the same partial year performance period as the composite.

HIBEV Top 5 Holdings


Symbol Name Current Price % Fund
BMRN Biomarin Pharmaceutical Inc $103.17 10.56%
ALXN Alexion Pharmaceuticals Inc $135.70 10.00%
INCY Incyte Corp $70.30 9.73%
ADMS Adamas Pharmaceuticals Inc $27.30 9.46%
FLXN Flexion Therapeutics Inc $27.47 9.35%
Total 49.09%

HIBEV Skill Metrics


Over the past years, Todd has invested in a total of 79 stocks at one time or another and made money on 46 (58.23%) of those stocks. Careful stock selection is one of the keys to success.

All Positions
Stock Picking Skills Winning % 58.23%
Trading Skills Avg. Gain/Loss Ratio 1.70